Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marchex (MCHX) EBITDA (2016 - 2025)

Marchex (MCHX) has disclosed EBITDA for 16 consecutive years, with -$941000.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBITDA fell 14.06% to -$941000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.9 million, a 23.94% decrease, with the full-year FY2024 number at -$4.4 million, up 53.88% from a year prior.
  • EBITDA was -$941000.0 for Q3 2025 at Marchex, down from -$535000.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$535000.0 in Q2 2025 to a low of -$5.2 million in Q1 2021.
  • A 5-year average of -$2.0 million and a median of -$1.6 million in 2024 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: soared 80.26% in 2021, then tumbled 194.12% in 2023.
  • Marchex's EBITDA stood at -$1.8 million in 2021, then tumbled by 96.98% to -$3.5 million in 2022, then surged by 68.17% to -$1.1 million in 2023, then tumbled by 41.57% to -$1.6 million in 2024, then skyrocketed by 40.71% to -$941000.0 in 2025.
  • Per Business Quant, the three most recent readings for MCHX's EBITDA are -$941000.0 (Q3 2025), -$535000.0 (Q2 2025), and -$1.9 million (Q1 2025).